{"id":16815,"date":"2023-06-08T14:14:58","date_gmt":"2023-06-08T12:14:58","guid":{"rendered":"http:\/\/mabdesign.fr\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/"},"modified":"2023-06-08T14:14:58","modified_gmt":"2023-06-08T12:14:58","slug":"peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/","title":{"rendered":"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant contre l\u2019arthrose"},"content":{"rendered":"<p>Paris, le 23 mai, 2023 &#8211; La soci\u00e9t\u00e9 de biotechnologie <strong>Peptinov<\/strong>, bas\u00e9e \u00e0 l\u2019h\u00f4pital Cochin (Paris), a lev\u00e9 4,67 millions d\u2019euros entre novembre 2022 et mars 2023 aupr\u00e8s de ses actionnaires historiques &#8211; notamment le groupe de protection sociale IRCEM, FCB (holding du groupe Cegedim) et BADGE (Business Angels des Grandes Ecoles). Ces fonds serviront \u00e0 financer la pr\u00e9paration de son essai clinique de phase 2 visant \u00e0 \u00e9valuer l\u2019efficacit\u00e9 de son traitement innovant \u2013 l\u2019immunoth\u00e9rapie mod\u00e9ratrice de la prot\u00e9ine IL- 6\u00a0 &#8211; dans l\u2019arthrose, et \u00e0 financer la pr\u00e9paration d\u2019essais cliniques dans de nouvelles indications. Peptinov a mis au point une approche unique qui permet au patient de produire des anticorps dirig\u00e9s contre ses propres prot\u00e9ines afin d\u2019\u00e9viter les cons\u00e9quences n\u00e9fastes d\u2019un exc\u00e8s de leur production. Ainsi la surproduction continue de la prot\u00e9ine inflammatoire IL-6, la premi\u00e8re cible de Peptinov, est un acteur majeur dans l\u2019instauration d\u2019une inflammation chronique, l\u2019inflammation de bas grade, \u00e0 l\u2019origine de nombreuses maladies. Enjeu majeur de sant\u00e9 publique, l\u2019arthrose fait partie des nombreuses maladies dont la progression pourrait \u00eatre stopp\u00e9e par le traitement de Peptinov. <a href=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/06\/CP-Peptinov-V9.1-23052023-.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">En savoir plus<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant \u2013 l\u2019immunoth\u00e9rapie mod\u00e9ratrice de la prot\u00e9ine IL- 6\u00a0 &#8211; dans l\u2019arthrose, et \u00e0 financer la pr\u00e9paration d\u2019essais cliniques dans de nouvelles indications.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9,13],"tags":[],"class_list":["post-16815","post","type-post","status-publish","format-standard","hentry","category-actualites","category-nos-adherents"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant contre l\u2019arthrose - MabDesign<\/title>\n<meta name=\"description\" content=\"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant \u2013 l\u2019immunoth\u00e9rapie mod\u00e9ratrice de la prot\u00e9ine IL- 6\u00a0 - dans l\u2019arthrose, et \u00e0 financer la pr\u00e9paration d\u2019essais cliniques dans de nouvelles indications.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant contre l\u2019arthrose - MabDesign\" \/>\n<meta property=\"og:description\" content=\"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant \u2013 l\u2019immunoth\u00e9rapie mod\u00e9ratrice de la prot\u00e9ine IL- 6\u00a0 - dans l\u2019arthrose, et \u00e0 financer la pr\u00e9paration d\u2019essais cliniques dans de nouvelles indications.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-08T12:14:58+00:00\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant contre l\u2019arthrose\",\"datePublished\":\"2023-06-08T12:14:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/\"},\"wordCount\":215,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Nos adh\u00e9rents\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/\",\"name\":\"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant contre l\u2019arthrose - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"datePublished\":\"2023-06-08T12:14:58+00:00\",\"description\":\"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant \u2013 l\u2019immunoth\u00e9rapie mod\u00e9ratrice de la prot\u00e9ine IL- 6\u00a0 - dans l\u2019arthrose, et \u00e0 financer la pr\u00e9paration d\u2019essais cliniques dans de nouvelles indications.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant contre l\u2019arthrose\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant contre l\u2019arthrose - MabDesign","description":"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant \u2013 l\u2019immunoth\u00e9rapie mod\u00e9ratrice de la prot\u00e9ine IL- 6\u00a0 - dans l\u2019arthrose, et \u00e0 financer la pr\u00e9paration d\u2019essais cliniques dans de nouvelles indications.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/","og_locale":"en_US","og_type":"article","og_title":"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant contre l\u2019arthrose - MabDesign","og_description":"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant \u2013 l\u2019immunoth\u00e9rapie mod\u00e9ratrice de la prot\u00e9ine IL- 6\u00a0 - dans l\u2019arthrose, et \u00e0 financer la pr\u00e9paration d\u2019essais cliniques dans de nouvelles indications.","og_url":"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/","og_site_name":"MabDesign","article_published_time":"2023-06-08T12:14:58+00:00","author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant contre l\u2019arthrose","datePublished":"2023-06-08T12:14:58+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/"},"wordCount":215,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"articleSection":["Actualit\u00e9s","Nos adh\u00e9rents"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/","url":"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/","name":"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant contre l\u2019arthrose - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"datePublished":"2023-06-08T12:14:58+00:00","description":"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant \u2013 l\u2019immunoth\u00e9rapie mod\u00e9ratrice de la prot\u00e9ine IL- 6\u00a0 - dans l\u2019arthrose, et \u00e0 financer la pr\u00e9paration d\u2019essais cliniques dans de nouvelles indications.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/peptinov-leve-467me-pour-levaluation-dun-traitement-innovant-contre-larthrose\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Peptinov l\u00e8ve 4,67M\u20ac pour l\u2019\u00e9valuation d\u2019un traitement innovant contre l\u2019arthrose"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=16815"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16815\/revisions"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=16815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=16815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=16815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}